Bigul

PFIZER LTD. - 500680 - Board Meeting Intimation for Board Meeting For The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2020.

PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2020 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, November 2, 2020, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2020. Pursuant to the 'Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders', the Trading Window of the Company was closed from Wednesday, September 30, 2020 (close of business) till 48 hours after the results are made public on November 2, 2020. We request you to kindly take the same on record.
22-10-2020
Bigul

US likely to have enough Covid-19 vaccines for all vulnerable Americans by year-end: Official

The US govt is cautiously optimistic that one or two vaccines, likely from Pfizer or Moderna, will be available by year end to be distributied to Americans
22-10-2020
Bigul

Pfizer, BioNTech start combined trials of Covid-19 vaccine candidate in Japan

Pfizer Inc and BioNTech SE announced on Tuesday the start in Japan of combined Phase I and Phase II clinical trials of their mRNA vaccine candidate
20-10-2020
Bigul

World Coronavirus Dispatch: WHO to revise guidance on Remdesivir soon

Pfizer to seek FDA approval for Covid -19 vaccine in November, coronavirus drives US budget deficit to record, and other pandemic-related news across the globe
17-10-2020
Bigul

PFIZER LTD. - 500680 - Compliance Certificate - Regulation 40 (9) Of The SEBI (LODR) Regulations, 2015.

In compliance with Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Certificate given by the Practicing Company Secretary, M/s. Manish Ghia & Associates, for the half year ended September 30, 2020.
15-10-2020
Bigul

COVID-19 vaccine: Pfizer to enroll participants as young as 12 in late-stage trials

While severe COVID-19 symptoms are extremely rare in infected children, they can pass on the virus to high-risk groups such as the elderly
14-10-2020
Bigul

PFIZER LTD. - 500680 - Compliance Certificate - Regulation 7(3) Of The SEBI (LODR) Regulations, 2015.

In compliance with Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Certificate from the Company and the Registrar and Share Transfer Agent for the half year ended September 30,2020.
14-10-2020
Bigul

PFIZER LTD. - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we furnish herewith Certificate dated October 12, 2020, issued by KFin Technologies Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended September 30, 2020. We request you to take the same on record.
14-10-2020
Bigul

PFIZER LTD. - 500680 - Statement Of Investor Complaints For The Quarter Ended September 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 025250 Name of the Signatory :- PRAJEET NAIRDesignation :- Company Secretary and Compliance Officer
14-10-2020
Bigul

PFIZER LTD. - 500680 - Shareholding for the Period Ended September 30, 2020

Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
13-10-2020
Next Page
Close

Let's Open Free Demat Account